#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation

Stay connected to the latest news with Physician’s Weekly

Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.

Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.

SUBSCRIBE NOW